SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 249.63 |
Enterprise Value ($M) | 188.61 |
Book Value ($M) | -61.65 |
Book Value / Share | -1.11 |
Price / Book | -4.05 |
NCAV ($M) | -94.93 |
NCAV / Share | -1.70 |
Price / NCAV | -2.63 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | n/a |
Return on Assets (ROA) | -0.32 |
Return on Equity (ROE) | n/a |
Liquidity (mrq) | |
---|---|
Quick Ratio | 3.16 |
Current Ratio | 3.16 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 225.42 |
Assets | 258.69 |
Liabilities | 320.34 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 22.60 |
Operating Income | -100.28 |
Net Income | -86.62 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -100.41 |
Cash from Investing | -29.90 |
Cash from Financing | 105.43 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Fmr Llc | 10.20 | -9.73 | |
13G/A | Klarman Family Foundation | 3.90 | ||
13G | Flynn James E | 5.31 | ||
13G | Biotechnology Value Fund L P | 9.99 | ||
13D/A | Flagship Ventures Fund V, L.P. | 22.90 | 28.64 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
20,914 | 67,275 | 31.09 | |
18,313 | 80,347 | 22.79 | |
126,815 | 220,971 | 57.39 | |
32,109 | 69,137 | 46.44 | |
28,428 | 106,717 | 26.64 | |
(click for more detail) |
Similar Companies | |
---|---|
ETNB – 89bio, Inc. | ETON – Eton Pharmaceuticals, Inc. |
FATE – Fate Therapeutics, Inc. | FOLD – Amicus Therapeutics, Inc. |
FULC – Fulcrum Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io